Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective
Abstract Nonalcoholic fatty liver disease (NAFLD) affects up to 70% of children with obesity and has become the number one etiology for liver transplant in the United States. Early, effective intervention is critical to prevent disease progression into adulthood. Yet, it is seldom achieved through l...
Saved in:
Main Authors: | Chance S. Friesen (Author), Sherwin S. Chan (Author), Jonathan B. Wagner (Author), Chelsea Hosey‐Cojocari (Author), Iván L. Csanaky (Author), Valentina Shakhnovich (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are body surface area based estimates of liver volume applicable to children with overweight or obesity? An in vivo validation study
by: Chelsea Hosey‐Cojocari, et al.
Published: (2021) -
Treatment of NAFLD: Diet, Physical Activity, and Potential Pharmacological Options
by: Justyna Śliz, et al.
Published: (2024) -
Pediatric growth patterns in youth‐onset type 2 diabetes mellitus: Implications for physiologically‐based pharmacokinetic models
by: Chelsea M. Hosey, et al.
Published: (2022) -
Editorial: Women in obstetric and pediatric pharmacology: 2021
by: Catherine M. Sherwin, et al.
Published: (2023) -
The Association between Pediatric NAFLD and Common Genetic Variants
by: Giuseppina Rosaria Umano, et al.
Published: (2017)